1.  Currently 150 Million people worldwide suffering from diabetes and that number may double by the year 2025.  The prevalence of type 2 diabetes is dramatically increasing among adolescents and teenages.  The death risk is 1.5 or 2.5 times bigger in people with diabetes than healthy people. Global Facts- Type 2 Diabetes WHO Technical Report series, No: 916, 2003

2.  Yet, worldwide there is a pandemic of type II diabetes and associated metabolic syndrome continue to take up an important space.  More than 10 % developing end-stage renal disease unless effective measures of early detection and intervention programs are initiated.

3. Global Facts -Hypertension  Hypertension causes cerebrovascular diseases (62 %) and iskemic heart disease (49 %).  Worldwide, high blood pressure is estimated to cause 7.1 million (13%) deaths. The World Health Report, 2002

4. HYPERTENSION  High Incidence of Hypertension  Cardiovascular and Renal Risk Increase: In USA: - 2002….. 261.000 mortality - 2005…..expenditure is 59 billion USD. A Serious Public Health Problem..

5. The Studies on Hypertension Prevalance  WHO MONICA Project: Multinational MONİtoring of Trends and Determinants in CArdiovascular Disease  Closer Countries  Hypertension prevalence and Blood Pressure Levels in 6 European Countries, Canada and United States  NHANES National Health and Nutrition Examination Survey  WHO MONICA Project: Multinational MONİtoring of Trends and Determinants in CArdiovascular Disease  Closer Countries  Hypertension prevalence and Blood Pressure Levels in 6 European Countries, Canada and United States  NHANES National Health and Nutrition Examination Survey

6. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) The consequences are rather interesting:  In Indian Males in Rural Regions 3.4 %  In Polish Females 72 %  Incidence in developed countries 20-50 %

7. In our country ;  There are 15 million hypertensives in adult population.  40 percent of them are aware that having high blood pressure.  31 percent of them have anti hypertensive therapy. The Prevalance Studies on Hypertension in Turkey (2004 ) Turkish Hypertension and Renal Diseases Association.

9. World Kidney Day Campaign aimed to reach basic targets in longer term.  Industry, the organizations which don’t belong to governments  National or Worldwide related organizations  Performers of Education and Policy, Public started to globally promote the campaign.

10. The public health mandate is clear for governments  Detection and prevention are the most cost effective methods to address chronic kidney disease and its impact on diabetes and cardiovascular disease.  www.world kidneyday.org www.world kidneyday.org

11.  Worldwide, most individuals with chronic kidney disease or hypertension are not diagnosed until long after the illness has developed.  Moreover, when they are diagnosed, they too often are treated suboptimally or not at all.  In most parts of the world, once end-stage kidney failure occurs, patients do not have access to maintenance hemodialysis treatment or kidney transplantation  And simply die. THE REAL PROBLEMS WE FACE

12.  For these problems, it is time to speak up and to speak clearly.  Because the extent and severity of kidney disease has not been appreciated for a long time.  Not only past, but also currently.  Moreover, the availability of easy methods for early detection and the proven benefits of preventive therapy are not widely known.  A day when attention to kidney disease is brought to the world’s population is timely.  It could also serve as a day to express appreciation for the billions of dollars of support for a disease that currently requires high- technology treatment.

13.  A day when we have to emphasize that early detection is more important in treatment.

15.  Cardiovascular complications can be prevented and effectively treated with  Intensive blood pressure control,  Glucose control in diabetic patients,  Lipid Lowering medications and use of kidney protective medications For instance: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.